PHP
Parkman Healthcare Partners Portfolio holdings
AUM
$864M
1-Year Return
33.7%
This Quarter Return
+23.8%
1 Year Return
+33.7%
3 Year Return
+258.24%
5 Year Return
+878.92%
10 Year Return
–
AUM
$376M
AUM Growth
+$23.8M
(+6.8%)
Cap. Flow
-$13M
Cap. Flow
% of AUM
-3.47%
Top 10 Holdings %
Top 10 Hldgs %
36.6%
Holding
101
New
12
Increased
44
Reduced
25
Closed
20
Top Buys
| 1 |
Humana
HUM
|
$8.93M |
| 2 |
Vaxcyte
PCVX
|
$7.58M |
| 3 |
United Therapeutics
UTHR
|
$5.13M |
| 4 |
SILK
Silk Road Medical, Inc. Common Stock
SILK
|
$4.93M |
| 5 |
Sarepta Therapeutics
SRPT
|
$4.58M |
Top Sells
| 1 |
CVS Health
CVS
|
$11.2M |
| 2 |
Waters Corp
WAT
|
$6.45M |
| 3 |
RCM
R1 RCM Inc. Common Stock
RCM
|
$5.16M |
| 4 |
Madrigal Pharmaceuticals
MDGL
|
$4.14M |
| 5 |
IQVIA
IQV
|
$4.06M |
Sector Composition
| 1 | Healthcare | 98.13% |
| 2 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BCYC
51
Bicycle Therapeutics
BCYC
$483M
| $2.7M | 0.72% |
91,332
+9,968
| +12% | +$295K |
|
52
KORU Medical Systems
KRMD
$190M
| $2.58M | 0.69% |
723,056
+39,590
| +6% | +$141K |
|
53
X4 Pharmaceuticals
XFOR
$81.7M
| $2.36M | 0.63% |
79,185
+47,518
| +150% | +$1.42M |
|
54
RxSight
RXST
$347M
| $2.24M | 0.6% |
176,421
+9,660
| +6% | +$122K |
|
55
Natera
NTRA
$22.9B
| $2.15M | 0.57% |
53,492
-51,709
| -49% | -$2.08M |
|
|
56
Madrigal Pharmaceuticals
MDGL
$9.61B
| $2.13M | 0.57% |
7,341
-14,249
| -66% | -$4.14M |
|
|
SLN
57
Silence Therapeutics
SLN
$247M
| $2.06M | 0.55% |
134,842
+7,384
| +6% | +$113K |
|
58
Axogen
AXGN
$709M
| $1.9M | 0.51% |
190,055
-9,945
| -5% | -$99.3K |
|
59
Arcus Biosciences
RCUS
$1.23B
| $1.81M | 0.48% |
87,460
-50,434
| -37% | -$1.04M |
|
60
Liquidia Corp
LQDA
$2.48B
| $1.71M | 0.46% |
269,192
+14,740
| +6% | +$93.9K |
|
61
Cogent Biosciences
COGT
$1.81B
| $1.64M | 0.44% |
141,582
-95,115
| -40% | -$1.1M |
|
|
ISEE
62
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $1.58M | 0.42% |
73,958
+23,958
| +48% | +$513K |
|
63
Fulcrum Therapeutics
FULC
$372M
| $1.51M | 0.4% |
206,866
-28,519
| -12% | -$208K |
|
64
Agios Pharmaceuticals
AGIO
$2.1B
| $1.4M | 0.37% |
+50,000
| New | +$1.4M |
|
65
Cullinan Oncology
CGEM
$408M
| $1.39M | 0.37% |
+131,378
| New | +$1.39M |
|
|
AKYA
66
DELISTED
Akoya BioSciences
AKYA
| $1.35M | 0.36% |
141,255
-20,446
| -13% | -$196K |
|
67
TELA Bio
TELA
$63M
| $1.34M | 0.36% |
116,668
+6,388
| +6% | +$73.5K |
|
68
Lifecore Biomedical
LFCR
$297M
| $1.32M | 0.35% |
203,578
+1,330
| +0.7% | +$8.62K |
|
69
Sight Sciences
SGHT
$195M
| $1.28M | 0.34% |
+105,102
| New | +$1.28M |
|
|
OPNT
70
DELISTED
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
| $1.22M | 0.32% |
59,943
-16,587
| -22% | -$336K |
|
71
Cytokinetics
CYTK
$5.95B
| $1.15M | 0.31% |
+25,000
| New | +$1.15M |
|
72
Mirum Pharmaceuticals
MIRM
$3.73B
| $1.03M | 0.27% |
52,754
+10,359
| +24% | +$202K |
|
73
Guardant Health
GH
$7.65B
| $952K | 0.25% |
+35,000
| New | +$952K |
|
74
Lexicon Pharmaceuticals
LXRX
$389M
| $804K | 0.21% |
421,202
+117,588
| +39% | +$225K |
|
75
Alpha Teknova
TKNO
$227M
| $725K | 0.19% |
128,458
+7,034
| +6% | +$39.7K |
|